- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Afatinib market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Afatinibmarket, defines the market attractiveness level of Afatinib market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Afatinib industry, describes the types of Afatinib market, the applications of major players and the market size, and deeply analyzes the current situation of the global Afatinib market and the development prospects and opportunities of Afatinib industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Afatinib market in Chapter 13.
By Player:
Beacon Pharma
Hengrui Medicine
Boehringer Ingelheim
By Type:
30mg Tables
40mg Tables
50mg Tables
25mg Tables
20mg Tables
Other
By End-User:
Hospital
Clinic
Drug Center
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Afatinib Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Afatinib Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Afatinib Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Afatinib Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Afatinib Market Analysis and Outlook to 2022
-
7.1 Global Afatinib Consumption (2017-2022)
-
7.2 United States Afatinib Consumption (2017-2022)
-
7.3 Europe Afatinib Consumption (2017-2022)
-
7.4 China Afatinib Consumption (2017-2022)
-
7.5 Japan Afatinib Consumption (2017-2022)
-
7.6 India Afatinib Consumption (2017-2022)
-
7.7 South Korea Afatinib Consumption (2017-2022)
8 Region and Country-wise Afatinib Market Analysis and Outlook to 2028
-
8.1 Global Afatinib Consumption Forecast (2022-2028)
-
8.2 United States Afatinib Consumption Forecast (2022-2028)
-
8.3 Europe Afatinib Consumption Forecast (2022-2028)
-
8.4 China Afatinib Consumption Forecast (2022-2028)
-
8.5 Japan Afatinib Consumption Forecast (2022-2028)
-
8.6 India Afatinib Consumption Forecast (2022-2028)
-
8.7 South Korea Afatinib Consumption Forecast (2022-2028)
9 Global Afatinib Market Outlook by Types and Applications to 2022
-
9.1 Global Afatinib Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 30mg Tables Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 40mg Tables Consumption and Growth Rate (2017-2022)
-
9.1.3 Global 50mg Tables Consumption and Growth Rate (2017-2022)
-
9.1.4 Global 25mg Tables Consumption and Growth Rate (2017-2022)
-
9.1.5 Global 20mg Tables Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Afatinib Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Drug Center Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Afatinib Market Outlook by Types and Applications to 2028
-
10.1 Global Afatinib Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 30mg Tables Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 40mg Tables Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global 50mg Tables Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global 25mg Tables Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global 20mg Tables Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Afatinib Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Drug Center Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Afatinib Import and Export Analysis (Top 5 Countries)
-
11.1 Global Afatinib Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Afatinib Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Afatinib Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Afatinib Market Competitive Analysis
-
14.1 Beacon Pharma
-
14.1.1 Beacon Pharma Company Details
-
14.1.2 Beacon Pharma Afatinib Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Beacon Pharma Afatinib Product and Service
-
14.2 Hengrui Medicine
-
14.2.1 Hengrui Medicine Company Details
-
14.2.2 Hengrui Medicine Afatinib Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Hengrui Medicine Afatinib Product and Service
-
14.3 Boehringer Ingelheim
-
14.3.1 Boehringer Ingelheim Company Details
-
14.3.2 Boehringer Ingelheim Afatinib Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Boehringer Ingelheim Afatinib Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Afatinib
-
Figure Afatinib Picture
-
Table Global Afatinib Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Afatinib Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Afatinib Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Afatinib Consumption by Country (2017-2022)
-
Figure United States Afatinib Consumption and Growth Rate (2017-2022)
-
Table Europe Afatinib Consumption and Growth Rate (2017-2022)
-
Figure China Afatinib Consumption and Growth Rate (2017-2022)
-
Figure Japan Afatinib Consumption and Growth Rate (2017-2022)
-
Figure India Afatinib Consumption and Growth Rate (2017-2022)
-
Figure South Korea Afatinib Consumption and Growth Rate (2017-2022)
-
Figure Global Afatinib Consumption Forecast by Country (2022-2028)
-
Figure United States Afatinib Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Afatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Afatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Afatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Afatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Afatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 30mg Tables Consumption and Growth Rate (2017-2022)
-
Figure Global 40mg Tables Consumption and Growth Rate (2017-2022)
-
Figure Global 50mg Tables Consumption and Growth Rate (2017-2022)
-
Figure Global 25mg Tables Consumption and Growth Rate (2017-2022)
-
Figure Global 20mg Tables Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Center Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global 30mg Tables Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 40mg Tables Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 50mg Tables Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 25mg Tables Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 20mg Tables Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug Center Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Afatinib Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Afatinib Export by Region (Top 5 Countries) (2017-2028)
-
Table Beacon Pharma (Foundation Year, Company Profile and etc.)
-
Table Beacon Pharma Afatinib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beacon Pharma Afatinib Product and Service
-
Table Hengrui Medicine (Foundation Year, Company Profile and etc.)
-
Table Hengrui Medicine Afatinib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hengrui Medicine Afatinib Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Afatinib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Afatinib Product and Service
-